NEW YORK (GenomeWeb News) - Virginia Commonwealth University’s School of Medicine is investigating a tissue-of-origin test made by Pathwork Diagnostics that is designed to help determine the origin of a malignant tumor, the company said today.
Pathwork Diagnostics’ Tissue of Origin Test, which uses Affymetrix microarrays and is still in clinical studies, measures 1,600 genes and compares one tissue’s genetic signature against those of other tissue types.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.